Associated Papers
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.
Schepisi G et al.
Esmo Open, 2025
Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC.
Cooper AJ et al.
Jto Clinical and Research Reports, 2022
36118132 (PubMed )
Supplement: mmc2.docx
Select a paper to view details